1Lepage JY, Melinovsky JM, Melinge M, et al. 51W89: Dose-response, neuromuscular blocking profile and cardiovascular effects [J]. Anesthesiology, 1993, 79(4): A943.
2Boyd AH, Eastwood NB, Parker CJ, et al. Pharmacodynamics of the 1R cis-1R cis isomer of atracrium (51W89) in health and chronic renal failure[J]. Br J Anaesth, 1995,74(2) :400 -404.
1Baraka A. Test dose for prediction of mivacurium sensitivity in the patient with atypical plasma cholinesterase [ J ]. Anesthesiology,1995, 83:1371 - 1372.
2Mcleod K, Watson M J, Rawlins MD. Pharmacokinetics of pancuronium in patients with normal and impaired renal function [J]. Br J Anaesth, 1976, 48:341 -345.
3Slater RM, Pollard B J, Doran BRH. Prolonged neuromuscular blockade with vecuronium in renal failure [ J ]. Anaesthesia, 1998,43:250 -251.
4Cooper RA, Maddineni VR, Mirakhur RK, et al. Time course of neuromuscular effects and pharmacokinetics of rocuronium bromide (ORG9426) during isoflurane anaesthsia in patients with and without renal failure[J]. BrJ Anaesth, 1993, 71:222 -226.
5Fahey MR, Rupp SM, Canfell C, et al. Effect of renal failure on laudanosine excretion in man [J]. Br J Anaesth, 1985, 57:1049-1051.
6Boyd AH, Eastwood NB, Parker CJR, et al. Pharmacodynamics of the IR cis -1 ' R cis isomer of atracurium (51W89) in health and renal failure[ J ]. Br J Anaesth, 1995, 74:400 - 404.
7Sztark F, Cantini O, Badie CB, et al. Continuous infusion of cisatracurium in patients with renal dysfunction [ J ]. Anesthesiology,1999,91: A1037.
1Frampton JE,McTavish D.Mivacurium.A review of its phar-macology and therapeutic potential in general anaesthesia[J].Drugs,1993,45(6):1066-1089.
2Ezzine,Samia,Donati,et al.Mivacurium arteriovenous gracii-ent during steady state infusion in anesthetized patients[J].An-esthesiology,2002,97(3):622-629.
3Abdulatif M.Recovery characteristics after early administra-tion of anticholinesterases during intense mivacurium-in-duced neuromuscular block[J].British Journal of Anaesthesia,1995,74:20-25.
4Adamus M,Koutna J,Gabrhelik T,et al. Influence of genderon the onset and duration of rocuronium-induced neuromus-cular block[J].Biomed Pap Med Fac Univ Palacky OlomouoCzech Repub,2007,151(2):301-305.
5Sorooshian SS,Stafford MA,Eastwood NB,et al.Pharmacoki-netics and pharmacodynamics of cisatracurium in young andelderly adult patients[J].Anesthesiology,1996,84(5):624-628.
